Opaleye Management Inc.

Position in STRO — Sutro Biopharma, Inc.

CIK 1595855 Boston, MA

Position in STRO

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$4,749,614

+$2,543,551 QoQ

Shares Held

190,671

0.0% QoQ

Ownership

1.15%

of shares outstanding

% of Portfolio

0.65%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Opaleye Management Inc. holds $678,840,611 across 50 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	IRON	Disc Medicine, Inc.	855,000	$62,534,700
2	URGN	UroGen Pharma Ltd.	1,439,996	$52,991,852
3	APGE	Apogee Therapeutics, Inc.	390,000	$51,764,700
4	MGTX	MeiraGTx Holdings plc	3,550,000	$47,960,500
5	SLGL	Sol-Gel Technologies Ltd.	500,000	$37,070,000
6	RZLT	Rezolute, Inc.	6,300,000	$32,760,000
7	TGTX	Tg Therapeutics, Inc.	535,000	$29,392,900
8	IMMX	Immix Biopharma, Inc.	2,345,000	$24,176,950

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$4,749,614	190,671	0.0%	Shares	Sole	2026-05-15
2025-12-31	$2,206,063	190,671	-36.8%	Shares	Sole	2026-04-13
2023-12-31	$1,293,396	301,491	-1.8%	Shares	Sole	2024-02-14
2023-06-30	$1,427,550	307,000	+241.2%	Shares	Sole	2023-08-14
2022-03-31	$739,635	89,980	-86.8%	Shares	Sole	2022-05-16
2021-12-31	$10,118,400	680,000	+26.4%	Shares	Sole	2022-02-14
2021-09-30	$10,159,042	537,800	+8.2%	Shares	Sole	2021-11-16
2021-06-30	$9,237,371	496,900	+45.3%	Shares	Sole	2021-08-16
2021-03-31	$7,782,782	341,950	+6.1%	Shares	Sole	2021-05-18
2020-12-31	$6,994,962	322,200	+120.7%	Shares	Sole	2021-02-12
2020-09-30	$1,467,300	146,000	—	Shares	Sole	2020-11-16
No filing history on record for this holder in this stock.